Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-14T16:28:00.678Z Has data issue: false hasContentIssue false
  • English
  • Français

Author's response

Published online by Cambridge University Press:  02 January 2018

Ilana B. Crome
Ilana B. Crome*
Affiliation:
Academic Director of Psychiatry, Professor of Addiction Psychiatry, Academic Psychiatry Unit, Keele University Medical School (Harplands Campus), Hilton Road, Harpfields, Stoke on Trent ST4 6TH, UK. E-mail: pca03@keele.ac.uk.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Correspondence
Information
Advances in Psychiatric Treatment , Volume 11 , Issue 2 , March 2005 , pp. 157
Copyright
Copyright © The Royal College of Psychiatrists 2005 

Of course, Dr Withecomb is correct. We should have stated that, although we prefer young people to participate in treatment (especially prescribing) with parental consent, if they are assessed as having the capacity and understanding to make decisions about treatment, they can decide about disclosure of information.

Submit a response

eLetters

No eLetters have been published for this article.